Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Market Cap	7.32B -3.9%
Revenue (ttm)	36.22B +4.4%
Net Income	730.47M +33.8%
EPS	0.20 +33.6%
Shares Out	n/a
PE Ratio	10.02
Forward PE	14.45
Dividend	0.06 (4.62%)
Ex-Dividend Date	Jul 15, 2026

Volume	n/a
Open	1.300
Previous Close	1.290
Day's Range	1.280 - 1.300
52-Week Range	1.160 - 1.420
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 49,608
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S1R

Financial Performance

In 2025, FRA:S1R's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 20, 2026

Data Sources Report a data error